BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 22079559)

  • 1. Repeated assessment of orthotopic glioma pO(2) by multi-site EPR oximetry: a technique with the potential to guide therapeutic optimization by repeated measurements of oxygen.
    Khan N; Mupparaju S; Hou H; Williams BB; Swartz H
    J Neurosci Methods; 2012 Feb; 204(1):111-117. PubMed ID: 22079559
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tissue pO2 of orthotopic 9L and C6 gliomas and tumor-specific response to radiotherapy and hyperoxygenation.
    Khan N; Li H; Hou H; Lariviere JP; Gladstone DJ; Demidenko E; Swartz HM
    Int J Radiat Oncol Biol Phys; 2009 Mar; 73(3):878-85. PubMed ID: 19136221
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dynamic changes in oxygenation of intracranial tumor and contralateral brain during tumor growth and carbogen breathing: a multisite EPR oximetry with implantable resonators.
    Hou H; Dong R; Li H; Williams B; Lariviere JP; Hekmatyar SK; Kauppinen RA; Khan N; Swartz H
    J Magn Reson; 2012 Jan; 214(1):22-8. PubMed ID: 22033225
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of hyperoxygenation on tissue pO2 and its effect on radiotherapeutic efficacy of orthotopic F98 gliomas.
    Khan N; Mupparaju S; Hekmatyar SK; Hou H; Lariviere JP; Demidenko E; Gladstone DJ; Kauppinen RA; Swartz HM
    Int J Radiat Oncol Biol Phys; 2010 Nov; 78(4):1193-200. PubMed ID: 20813466
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Skeletal muscle and glioma oxygenation by carbogen inhalation in rats: a longitudinal study by EPR oximetry using single-probe implantable oxygen sensors.
    Hou H; Khan N; Lariviere J; Hodge S; Chen EY; Jarvis LA; Eastman A; Williams BB; Kuppusamy P; Swartz HM
    Adv Exp Med Biol; 2014; 812():97-103. PubMed ID: 24729220
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Repeated tumor oximetry to identify therapeutic window during metronomic cyclophosphamide treatment of 9L gliomas.
    Mupparaju S; Hou H; Lariviere JP; Swartz H; Jounaidi Y; Khan N
    Oncol Rep; 2011 Jul; 26(1):281-6. PubMed ID: 21503586
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Repeated tumor pO(2) measurements by multi-site EPR oximetry as a prognostic marker for enhanced therapeutic efficacy of fractionated radiotherapy.
    Hou H; Lariviere JP; Demidenko E; Gladstone D; Swartz H; Khan N
    Radiother Oncol; 2009 Apr; 91(1):126-31. PubMed ID: 19013657
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessment of the changes in 9L and C6 glioma pO2 by EPR oximetry as a prognostic indicator of differential response to radiotherapy.
    Hou H; Mupparaju SP; Lariviere JP; Hodge S; Gui J; Swartz HM; Khan N
    Radiat Res; 2013 Mar; 179(3):343-51. PubMed ID: 23391148
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumor pO₂ as a surrogate marker to identify therapeutic window during metronomic chemotherapy of 9L gliomas.
    Mupparaju S; Hou H; Lariviere JP; Swartz HM; Khan N
    Adv Exp Med Biol; 2011; 701():107-13. PubMed ID: 21445776
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of RSR13, an allosteric hemoglobin modifier, on oxygenation in murine tumors: an in vivo electron paramagnetic resonance oximetry and bold MRI study.
    Hou H; Khan N; O'Hara JA; Grinberg OY; Dunn JF; Abajian MA; Wilmot CM; Makki M; Demidenko E; Lu S; Steffen RP; Swartz HM
    Int J Radiat Oncol Biol Phys; 2004 Jul; 59(3):834-43. PubMed ID: 15183487
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased oxygenation of intracranial tumors by efaproxyn (efaproxiral), an allosteric hemoglobin modifier: In vivo EPR oximetry study.
    Hou H; Khan N; O'Hara JA; Grinberg OY; Dunn JF; Abajian MA; Wilmot CM; Demidenko E; Lu S; Steffen RP; Swartz HM
    Int J Radiat Oncol Biol Phys; 2005 Apr; 61(5):1503-9. PubMed ID: 15817356
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of a clinically used charcoal suspension for in vivo EPR oximetry.
    Desmet CM; Tran LBA; Danhier P; Gallez B
    MAGMA; 2019 Apr; 32(2):205-212. PubMed ID: 30209636
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modulation of tumor hypoxia by topical formulations with vasodilators for enhancing therapy.
    Abramovic Z; Hou H; Julijana K; Sentjurc M; Lariviere JP; Swartz HM; Khan N
    Adv Exp Med Biol; 2011; 701():75-82. PubMed ID: 21445772
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Direct and Repeated Measurement of Heart and Brain Oxygenation Using In Vivo EPR Oximetry.
    Khan N; Hou H; Swartz HM; Kuppusamy P
    Methods Enzymol; 2015; 564():529-52. PubMed ID: 26477264
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synergistic combination of hyperoxygenation and radiotherapy by repeated assessments of tumor pO2 with EPR oximetry.
    Hou H; Dong R; Lariviere JP; Mupparaju SP; Swartz HM; Khan N
    J Radiat Res; 2011; 52(5):568-74. PubMed ID: 21799293
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cerebral oxygenation of the cortex and striatum following normobaric hyperoxia and mild hypoxia in rats by EPR oximetry using multi-probe implantable resonators.
    Hou H; Li H; Dong R; Mupparaju S; Khan N; Swartz H
    Adv Exp Med Biol; 2011; 701():61-7. PubMed ID: 21445770
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A comparative evaluation of EPR and OxyLite oximetry using a random sampling of pO(2) in a murine tumor.
    Vikram DS; Bratasz A; Ahmad R; Kuppusamy P
    Radiat Res; 2007 Sep; 168(3):308-15. PubMed ID: 17705635
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quantitative imaging of pO
    Yasui H; Kawai T; Matsumoto S; Saito K; Devasahayam N; Mitchell JB; Camphausen K; Inanami O; Krishna MC
    Free Radic Res; 2017 Oct; 51(9-10):861-871. PubMed ID: 29076398
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical electron paramagnetic resonance (EPR) oximetry using India ink.
    Williams BB; Khan N; Zaki B; Hartford A; Ernstoff MS; Swartz HM
    Adv Exp Med Biol; 2010; 662():149-56. PubMed ID: 20204785
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intracellular hypoxia of tumor tissue estimated by noninvasive electron paramagnetic resonance oximetry technique using paramagnetic probes.
    Matsumoto A; Matsumoto K; Matsumoto S; Hyodo F; Sowers AL; Koscielniak JW; Devasahayam N; Subramanian S; Mitchell JB; Krishna MC
    Biol Pharm Bull; 2011; 34(1):142-5. PubMed ID: 21212532
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.